As part of the second annual “I Am CardioSmart” contest, the American College of Cardiology is encouraging patients who are living well with heart disease to share their stories to inspire others to take charge of their heart health. Patients living with high blood pressure, heart failure, atrial fibrillation, a congenital heart defect, coronary artery …
Read More
In December of 2012, the American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts will be sponsoring three Living with Atrial Fibrillation programs in Dallas, Houston, and Tampa. Learn more at: American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts are sponsoring Living with Atrial Fibrillation programs
Read More
The American College of Cardiology recently interviewed our founder and CEO, Mellanie True Hills, about how she came to start Atrial Fibrillation Awareness Month and what has happened as a result. Access the video at: American College of Cardiology Interviews StopAfib.org Founder About Having Created Atrial Fibrillation Awareness Month
Read More
There was an update today on the long-awaited FDA status of Atritech's WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced …
Read More
Genetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31%, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots …
Read More
A new study just presented at the American College of Cardiology scientific sessions found psoriasis to be a significant and independent risk factor for atrial fibrillation (AF) and a stroke risk factor, too. Mild psoriasis increases afib risk by 22% while moderate-to-severe psoriasis raises afib risk by 51%. This chronic inflammatory condition also raises other …
Read More
There is a lot of news coming out of the American College of Cardiology annual meetings going on currently in Orlando. One such story, about the Watchman device trial, is particularly important to those with afib who are concerned about blood clots and stroke. Read more at: Watchman Device as Alternative to Warfarin or Coumadin
Read More